INS and obesity due to melanocortin 4 receptor deficiency: Preventing or reversing elevated insulin levels in PWS with pharmacological agents39, 40 and/or through diet restrictions such as a combined low carbohydrate, low glycemic‐load diet41, 42 may be a viable therapeutic strategy in combating obesity in children with PWS and others with early childhood obesity.